• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares (NQ:LSE)

5.260 -0.210 (-3.84%)
Streaming Delayed Price Updated: 1:06 PM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,407
Open 5.720
Bid (Size) 5.000 (3,000)
Ask (Size) 5.680 (1,300)
Prev. Close 5.470
Today's Range 5.260 - 5.720
52wk Range 3.200 - 6.980
Shares Outstanding 17,025,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma
August 27, 2026
Novel, highly potent oral selective FGFR 1/2/3 inhibitor approved for patients with advanced FGFR2-altered intrahepatic cholangiocarcinoma in China 
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®
August 16, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire

Performance

YTD
+23.2%
+23.2%
1 Month
+3.8%
+3.8%
3 Month
+22.0%
+22.0%
6 Month
+12.6%
+12.6%
1 Year
-3.5%
-3.5%

More News

Read More
News headline image
Public Policy Holding Company, Inc. Announces Q2 2026 Financial Results
August 10, 2026
From Public Policy Holding Company, Inc.
Via GlobeNewswire
News headline image
TierPoint Launches Adapt DDoS Protection
August 04, 2026
From TierPoint
Via GlobeNewswire
News headline image
PPHC Acquires Florida Government Relations Firm
August 03, 2026
From Public Policy Holding Company, Inc.
Via GlobeNewswire
News headline image
HUTCHMED Reports 2026 Interim Results
July 30, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
PPHC to Report Second Quarter 2026 Financial Results and Present at Upcoming Investor Conference
July 27, 2026
From Public Policy Holding Company, Inc.
Via GlobeNewswire
News headline image
PPHC Strengthens Public Affairs Offering with Hire of Managing Director and Content Specialist
July 14, 2026
From Public Policy Holding Company, Inc.
Via GlobeNewswire
News headline image
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
July 08, 2026
From Avacta Group PLC
Via GlobeNewswire
News headline image
HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification
July 02, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
PPHC Announces Acquisition of Tancredi
July 01, 2026
From Public Policy Holding Company, Inc.
Via GlobeNewswire
News headline image
HUTCHMED to Announce 2026 Half-Year Financial Results
June 30, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026
June 24, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Leishen Energy Named as the No. 1 Bid Winner for Surface Control Integrated Devices with a Sinopec Oilfield
June 16, 2026
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
News headline image
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
June 11, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026
June 01, 2026
From Avacta Group PLC
Via GlobeNewswire
News headline image
PPHC to Participate in Stifel’s Ninth Annual Boston Cross Sector 1x1 Conference
May 29, 2026
From Public Policy Holding Company, Inc.
Via GlobeNewswire
News headline image
HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting
May 21, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
May 21, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Alpha FMC Appoints Charles Cummins as Senior Partner in North American Wealth Management Team
May 20, 2026
From Alpha FMC
Via GlobeNewswire
News headline image
Metals One to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21st
May 20, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Unaudited Preliminary Results for the Year Ended December 31, 2025
May 19, 2026
From Avacta Group PLC
Via GlobeNewswire
News headline image
Amaroq Ltd to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21st
May 18, 2026
From Virtual Investor Conferences
Via GlobeNewswire

Frequently Asked Questions

Is Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares publicly traded?
Yes, Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is publicly traded.
What exchange does Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares trade on?
Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?
The ticker symbol for Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is LSE on the Nasdaq Stock Market
What is the current price of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?
The current price of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is 5.260
When was Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares last traded?
The last trade of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares was at 08/28/26 01:06 PM ET
What is the market capitalization of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?
The market capitalization of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is 89.55M
How many shares of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares are outstanding?
Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares has 90M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap